Cubist Systematic Strategies, LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 143 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$48,000
-18.6%
13,200
-34.0%
0.00%
-50.0%
Q1 2019$59,000
-58.5%
19,998
-77.5%
0.00%
-71.4%
Q4 2018$142,000
+238.1%
88,995
+687.0%
0.01%
+250.0%
Q3 2018$42,000
-71.4%
11,308
-78.2%
0.00%
-71.4%
Q2 2018$147,000
+188.2%
51,910
+193.4%
0.01%
+133.3%
Q4 2017$51,000
-25.0%
17,692
+112.1%
0.00%
-25.0%
Q3 2016$68,000
-21.8%
8,340
-24.9%
0.00%
-20.0%
Q2 2016$87,000
+1.2%
11,0980.0%0.01%0.0%
Q1 2016$86,000
-28.3%
11,0980.0%0.01%
-28.6%
Q4 2015$120,000
+55.8%
11,0980.0%0.01%
+75.0%
Q3 2015$77,000
-21.4%
11,0980.0%0.00%
-20.0%
Q2 2015$98,000
-84.8%
11,098
-83.0%
0.01%
-83.9%
Q1 2015$643,000
+312.2%
65,240
+413.4%
0.03%
+287.5%
Q4 2014$156,000
-83.7%
12,707
-86.7%
0.01%
-86.2%
Q3 2014$957,000
+369.1%
95,892
+256.0%
0.06%
+383.3%
Q2 2014$204,00026,9370.01%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q3 2015
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$57,396,0007.04%
HealthInvest Partners AB 497,807$2,096,0003.21%
BVF INC/IL 3,285,400$13,832,0002.35%
EMORY UNIVERSITY 486,438$2,048,0001.93%
Marcus Capital, LLC 69,400$1,751,0001.63%
DAFNA Capital Management LLC 196,500$827,0000.70%
Orbimed Advisors 13,107,200$55,181,0000.62%
Rock Springs Capital Management LP 1,500,000$6,315,0000.36%
Spark Investment Management LLC 710,100$2,989,0000.19%
TURNER INVESTMENTS LLC 65,420$275,0000.18%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders